论文部分内容阅读
目的探讨高丽参注射液在晚期乳腺癌治疗中的价值和作用。方法57例患者采用随机对照,分为治疗组(高丽参注射液联合化疗)30例和对照组(单用化疗)27例,分别比较各组近期疗效、生活质量、不良反应。结果治疗组稳定率(CR+PR+SD)明显优于对照组,有显著差异(P<0.05)、生活质量明显提高(P<0.01)、不良反应减轻(P<0.05);治疗组有效率(CR+PR)高于对照组,但无统计学意义(P>0.05)。结论高丽参注射液联合化疗可提高患者生活质量,减轻化疗药物的毒副反应,保护患者的免疫功能,增强化疗耐受性,值得临床推广。
Objective To investigate the value and effect of Ganoderma Injection in the treatment of advanced breast cancer. Methods 57 patients were randomized and divided into treatment group (Ginseng injection combined with chemotherapy) in 30 cases and control group (single use of chemotherapy) in 27 cases. The short-term efficacy, quality of life, and adverse reactions were compared in each group. Results The stability rate of the treatment group (CR+PR+SD) was significantly better than that of the control group. There was significant difference (P<0.05), the quality of life was significantly improved (P<0.01), and adverse reactions were reduced (P<0.05). The treatment group was effective. (CR+PR) was higher than the control group, but not statistically significant (P>0.05). Conclusion Ginseng Injection combined with chemotherapy can improve the quality of life of patients, reduce the toxic and side effects of chemotherapy drugs, protect the patient’s immune function, and enhance the tolerance of chemotherapy, which is worthy of clinical promotion.